Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
- Posted on March 25, 2026
- By CNBC
- 7 Views
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.
